Literatur

Ahnhudt C, Muche M, et al.: An approach to the sensitivity of temperaturgradient gel electrophoresis in the detection of clonally expanded T-cells in cutaneous T-cell lymphoma. Electrophoresis 2001; 22 :33-38

Bernengo M, Quaglino P, et al.: Prognostic factors in Sézary syndrome: A multivariate analysis of clinical, haematological and immunological features. Annals of Oncology 1998;9 :857-863

Bernengo M, Novelli M, et al.: The relevance of the CD4+CD26- subset in the identification of circulating Sézary cells. Br J Dermatol 2001 ;144 :125-135

Bigler R, Boselli C, et al.: Failure of anti-T-cell receptor V beta antibodies to consistently identify a malignant T-cell clone in Sezary syndrome. Am J Pathol 1996 ;149:1477-1483

Breit T, Wolvers-Tettero I, et al.: Receptor diversity of human T-cell receptor γ δ expressing cells. Progress in Histo- and Cytochemistry 1992 ;26:182-193

Breslauer K, Frank R, et al.: Predicting DNA duplex stability from the base sequence. Proceedings of the National Academy of Science of the USA 1986;83: 3746-3750

Bogen S, Pelley D, et al.: Immunophenotypic Identification of Sezary Cells in the Peripheral Blood. Am J Clin Pathol 1996 ;106 :739-748

Bsnier E, Hallopeau: On the erythrodermia of Mycosis fungoides. J Cutan Genitouri Disease 1892;10:453

Buechner S, Winkelmann R: Sézary Syndrome: A clinicopathologic Study of 39 Cases. Arch Dermatol 1983;119:979-986

Burg G, Dummer R, et al.: Classification of Cutaneous Lymphomas. Dermatologic Clinics 1994 ;12 (2): 213-217

Chan A, Reynolds P, et al.: Tyrosine kinase activity associated with the CD7 antigen: correlation with regulation of T cell integrin function. Eur J Immunol 1994;24:2602-2608

Chan D, Liang R, et al.: Detection of T-Cell Receptor Delta Gene Rearrangement in T-Cell Maligancies by Clonal Specific Polymerase Chain Reaction and its Application to detect minimal residual Disease . American Journal of Hematology 1996 ; 52 : 171-177

Dongen J, Comans-Bitter M, et al.: Development of human T lymphocytes and their thymus-dependency. Thymus 1990;16 (3-4):207-234

Dummer R, Haeffner A, et al.: Cutaneous T-Cell lymphomas (CTCL): new aspects in PCR-based diagnostic tools, immunology and treatment. Eur J Dermatol 1994;4 (4): 281-286

Dummer R, Nestle F, et al.: Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD7- T lymphocyte subsets in Sézary syndrome. Arch Dermatol Res 1999;291:307-311

Dummer R, Nestle F, et al.: Pathogenesis of Cutaneous Lymphomas. Semin Cutan Med Surg 2000;19:78-86

Dummer R, Willers J, et al.: Aktuelle Aspekte zur Pathogenese von Sézary-Syndrom und Mycosis fungoides. Hautarzt 2001;52: 189-192

Eckert C, Landt O, et al.: Potential of LightCycler technology for quantification of minimal residual disease in childhood acute lymphoblastic leukemia: Leukemia 2000;14(2):316-23

Edelson R, Lutzner M: Morphologic and functional properties of the atypical T-Lymphocytes of Sézary Syndrome. Mayo Clin Proc 1974;49: 558-66

Edelson R: Cutaneous T cell lymphoma: Mycosis fungoides, Sézary syndrome, and other variants. J Am Acad Dermatol 1980;2(2): 89-106

Fink-Pouches R., Zenahlik P., et al.: Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients. Blood 2002;99(3): 800-805

Forster A, Huck S, et al.: New subgroups in the human T-cell rearranging V(gamma) gene locus. EMBO 1987;6: 1945 -50

Fraser-Andrews E, Russel-Jones R, et al.: Diagnostic and Prognostic Importance of T-Cell Receptor Gene Analysis in Patients with Sézary Syndrome. Cancer 2001;92:1745-1752

Fritsch: “Dermatologie und Venerologie”-Lehrbuch und Atlas, Springer 1998;634-639

Ginaldi L, Farahat N, et al.: Differential expression of T cell antigens in normal peripheral blood lymphocytes: a quantitative analysis by flow cytometrie. J Clin Pathol 1996;49:539-544

Ginés S, Marino M, et al.: Regulation of epithelial and lymphocyte cell adhesion by adenosine deaminase-CD26 interaction. Biochem J 2002;361:203-209

Gorrell M, Gysbers V, et al.: CD26: A Multifunctional Integral Membrane and Secretes Protein of Activated Lymphocytes. Scand J Immunol 2001;54:249-264

Gutzmer R, Mommert S, et al.: Detection of Clonal T Cell Receptor γ Gene Rearrangements in Cutaneous T Cell Lymphoma by LightCycler-Polymerase Chain Reaction. J Invest Dermatol 2001;116:926-932

Harris N., Jaffe E., et al.: A Revised European-American Classification of Lymphoid Neoplasms: A Proposal From the International Lymphoma Study Group. Blood 1994;84(5): 1361-1392

Harmon C, Witzig T, et al.: Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses. J Am Acad Dermatol 1996;35:404-410

Haynes B, Bunn P, et al.: Cell surface Differentiation Antigens of the Malignant T Cell in Sezary Syndrome and Mycosis Fungoides . J Clin Invest 1981; 67:523-530

Hildebrandt M, Reutter W, et al.: A guardian angel: the involvement of dipeptidyl peptidase IV in psychoneuroendocrine function, nutrition an immune defence. Clin Science 2000;99:93-104

Isaacson P, Norton A: “Extranodal Lymphoma” Churchill Livingstone 1994; 172

Jaffe E, Harris N, et al.: World Health Organization Classification of neoplastic diseases of the hematopoietic and lymphoid tissues . Am J Clin Pathol 1999;S8-S12

Jakob T, Neuber K, et al.: Stage-dependent Expression of CD7, CD45RO, CD45RA and CD25 on CD4-positive Peripheral Blood T-Lymphocytes in Cutaneous T-cell Lymphoma. Acta Derm Venereol 1996;76:34-36

Johnson G, Dewald G, et al.: Chromosome studies in 17 patients with the Sezary syndrome. Cancer 1985;55(10):2426-2433

Jones D, Dang N, et al.: Absence of CD26 Expression Is a Useful Marker for Diagnosis of T-Cell Lymphoma in peripheral Blood. Am J Clin Pathol 2001;115:885-892

Jung R, Soondrum K, et al.: Quantitative PCR. Clin Chem Lab Med 2000; 38(9):833-836

Kneba M, Bolz I, et al.: Characterization of Clone-Specific Rearranged T-Cell Receptor γ -Chain Genes in Lymphomas and Leukemias by the Polymerase Chain Reaction and DNA Sequencing. Blood 1994;84(2):574-581

Kneba M, Bolz I, et al.: Analysis of rearranged t cell receptor β -chain genes by polymerase chain reaction (PCR) DNA sequencing and automated high resolution PCR Fragment Analysis. Blood 1995;96: 3930-37

Kukel S, Reinhold U, et al.: Progressive increase of CD7- T cells in human blood lymphocytes with ageing. Clin Exp Immunol 1994;98:163-168

Laetsch B, Haeffner A, et al.: CD4+/CD7- T Cell Frequency and Polymerase Chain Reaction-Based Clonality Assay Correlate with Stage in Cutaneous T Cell Lymphoma. J Inv Dermatol 2000;14(1):107-111

Lazarovits A, Osman N, et al.: CD7 is Associated with CD3 and CD45 on Human T Cells. J Immunol 1994;153:3956-3966

Lee B, Duvic M, et al.: Dysregulated Synthesis of Intracellular Type 1 and Type 2 Cytokines by T Cells of Patients with Cutaneous T Cell Lymphoma. Clin Diag Lab Immunol 1999;6(1):79-84

Lefranc M, Chuchana P, et al.: Molecular mapping of the human T-cell receptor gamma (TRG) genes and linkage of the variable and constant regions. Eur J Immunol 1989;19: 989-94

Lessin S, Rook A, et al.: Molecular Diagnosis of Cutaneous T-Cell Lymphoma: Polymerase Chain Reaction Amplification of T-Cell Antigen Receptor β -Chain Gene Rearrangements. J Invest Dermatol 1991;91:299-302

Liu L, Abken H, et al.: Accumulation of CD4+CD7- T cells in inflammatory skin lesions: evidence for preferential adhesion to vascular endothelial cells. Clin Exp Immunol 2000;121:94-99

Lukowsky A, Audring H, et al.: Nachweis von monoklonalen T-Zellen mittels TCR γ -PCR bei Mycosis Fungoides(MF). Hautarzt 1998;49:641-645

Lukowsky A, Muche M, et al.: Detection of expanded T Cell Clones in Skin Biopsy Samples of Patients with Lichen Sclerosus et atrophicus by T Cell Receptor- γ Polymerase Chain Reaction Assays . J Invest Dermatol 2000;115(2):254-259

Lutzner M, Jordan H: The ultrastructure of an abnormal cell in Sézary Syndrom. Blood 1968;31:719-726

Meyer C, Leeuwen A, et al.: Cerebriform (Sezary Like) Mononuclear Cells in Healthy Individuals: A Morphologically Distinct Population of T Cells. Virchows Arch B Cell Path 1977;25:95-104

Meyer J, Hassam S, et al.: A realistic approach to the sensitivity of PCR-DGGE and its application as a sensitive tool for the detection of clonality in cutaneous T-cell proliferations. Exp Dermatol 1997;6(3):122-127

Mielke V, Staib G, et al.: Clonal disease in early cutaneous T-cell lymphoma. Dermatol Clin 1994;12:351-360

Moss P, Charmley P, et al.: The Repertoire of T Cell Antigen Receptor β -Chain Variable Regions Associated with Psoriasis Vulgaris. J Invest Dermatol 1997;109(1):14-19

Muche M : PCR- und Elektrophoresetechniken zum Nachweis einer monoklonalen T-Zell-Vermehrung am Beispiel der Diagnostik der Mycosis fungoides. Dissertation 1995.

Muche M, Lukowsky A, et al.: Demonstration of Frequent Occurrence of Clonal T-Cells in the Peripheral Blood of Patients With Primary Cutaneous T-Cell Lymphoma. Blood 1997;90(4):1636-1642

Muche M, Lukowsky A, et al.: Demonstration of frequent occurrence of clonal T cells in the peripheral blood but not in the skin of patients with small plaque parapsoriasis. Blood. 1999;94(4):1409-1417

Muche M, Gellrich S, et al.: Treatment of Cutaneous T-Cell Lymphomas. Sem Cut Med Surg 2000; 19(2):142-148

NCBI-Database: http:///www.ncbi.nlm.nih.gov/blast

Novelli M, Quaglino P, et al.: CD4+CD26- Evaluation is a more useful Diagnostic Parameter than CD4+CD7- in Sezary Syndrome(SS). J Invest Dermatol 1995;105(3):515

Ostendorf P, Seeber S: Hämatologie Onkologie. Urban & Schwarzenberg 1997;33-38

Pace K, Hahn H, et al.: Cutting Edge: CD7 Delivers a Pro-Apoptotic Signal During Galectin-1-Induced T Cell Death. J Immunol 2000;165:2331-2334

Pfitzner T, Reiser M, et al.: Quantitative molecular monitoring of residual tumor cells in chronic lymphocytic leukemia. Ann Hematol 2002;81(5):258-266

Powell E, Kroon P, et al.: Measurement of mRNA by quantitative PCR with nonradioactive label. J Lipid Res 1992; 33: 609-14

Rappl G, Muche M, et al.: CD4+CD7- T cells compose the dominant T-cell clone in the peripheral blood of patients with Sézary syndrome. J Am Acad Dermatol 2001;44(3):456-461

Rappl G, Abken H, et al.: CD4+CD7- leukemic T cells from patients with Sézary syndrome are protected from galectin-1-triggered T cell death. Leukemia 2002;16:840-845

Rasmussen R.: Quantification on the LightCycler. in Meuer S, et al.: Rapid cycle real-time PCR, Springer, Heidelberg 2001: 21-35

Reischl U, Kochanowski B: Quantitative PCR. Molecular Biotechnology 1995;3: 55-71

Reinhold U, Abken H, et al.: CD7- T Cells Represent a subset of Normal Human Blood Lymphocytes. J Immunol 1993;150(5):2081-2089

Reinhold U, Liu L, et al.: CD7-negative T cells represent a seperate differention pathway in a subset of post-thymic helper T cells . Immunology 1996;89:391-396

Roche Molecular Biochemicals (a) : Li ght-Cycler-System. Real-time PCR- as flexible as you are. 2000; 12-14

Roche Molecular Biochemicals : Overview of Lightcycler quantification methods, Technical Note LC 2000; 10:11

Rowen L, Koop B, et al.: The complete 685-kilobase DNA sequence of the human beta cell receptor locus. Science 1996; 272:1755-1762

Russel-Jones R, Whittaker S: T-cell receptor gene analysis in the diagnosis of Sézary Syndrome . J Am Acad Dermatol 1999;41(2):254-258

Russel-Jones R, Whittaker S: Sézary Syndrome: Diagnostic Criteria and therapeutic Options. Sem Cut Med Surg 2000;19(2):100-108

Sarris A, Jiang Y, et al.: Quantitative Real-Time Polymerase Chain Reaction for Monitoring Minimal Residual Disease in Patients With Advanced Indolent Lymphomas Treated with Rituximab, Fludarabine, Mitoxantrone, and Dexamethasone. Semin Oncol 2002;29(2):48-55

Scala E, Russo G, et al.: Skewed Expression of Activation, Differentiation and Homing-Related Antigens in Circulating Cells from Patients with Cutaneous T Cell Lymphoma Associated with CD7- T Helper Lymphocytes Expansion. J Invest Dermatol 1999;113:622-627

Scarisbrick J, Whittacker S, et al.: Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma. Blood 2001;97 (3):624-629

Scarisbrick J, Woolford A, et al.: Allelotyping in Mycosis Fungoides and Sezary Syndrome: Common Regions of Allelic Loss Identified on 9p, 10q, and 17p. J Invest Dermatol 2001;117(3):663-670

Scarisbrick J, Woolford A, et al.: Frequent Abnormalities of the P15 and P16 Genes in Mycosis Fungoides and Sezary Syndrome. J Invest Dermatol 2002;118(3): 493-499

Schwab C, Willers J, et al.: The use of anti-T-cell receptor-V β antibodies for the estimation of treatment success and phenotypic characterization of clonal T-cell populations in cutaneous T-cell lymphomas. Br J Haematol 2002; 118:1019-1026

Sézary A, Bouvrain Y: Erythrodermie avee presence de cellules monstreuses dans le derme et dans le sang circulant. Bull Soc Fr Dermatol Syph 1938;45:254-260

Sempowski G, Lee D, et al.: Structure and Function of the CD7 Molecule. Crit Rev Immunol 1999;19:331-348

Sharp J, Chan W: Detection and relevance of minimal disease in lymphomas. Cancer Metastasis Rev 1999;18(1): 127-142

Sterry W, Mielke V, et al.: CD4+ Cutaneous T-Cell Lymphomas Show the Phenotype of Helper/Inducer T Cells (CD45RA-, CDw29+). J Invest Dermatol 1989;93:412-416

Taswell H, Winkelmann R: Sézary Syndrome - a malignant reticulemic erythroderma. JAMA 1961;117:465-472

Trainor K.J., Brisco M.J., et al.: Gene Rearrangement in B- and T- Lymphoproliferative Desease Detected by the Polymerase Chain Reaction. Blood 1991;78(1):192-196

Veelken H, Wood G, et al.: Molecular Staging of Cutaneous T-Cell Lymphoma: Evidence for Systemic Involvement in Early Disease . J Invest Dermatol 1995;104:889-894

Verstovsek S, Cabanillas F, et al.: CD26 in T-Cell Lymphomas: A Potential Clinical Role?. Oncology 2000;14(6):17-23

Volkenandt M, Soyer H, et al.: Development of a Highly Specific and Sensitive Molecular Probe for Detection of Cutaneous Lymphoma. J Invest Dermatol 1991;97 :137-140

Volkenandt M, Soyer H, et al.: Molecular detection of clone-specific DNA in hypopigmented lesions of a patient with early evolving mycosis fungoides. Br J Dermatol 1993;128:423-428

Vonderheid E, Bigler R, et al.: Variable CD7 Expression on T Cells in the Leukemic Phase of Cutaneous T Cell Lymphoma (Sezary Syndrome). J Invest Dermatol 2001;117(3): 654-662

Vonderheid E, Bernengo G, et al.: Update on erythrodermic cutaneous T-cell lymphoma: Report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 2002;46:95-106

Weinberg J, Jaworsky C, et al.: The Clonal Nature of Circulating Sezary Cells. Blood 1995;86(11):4257-4262

Wetmur J. : DNA probes: applications of the principles of nucleic acid hybridization. Critical Revue in Biochemistry and Molecular Biology 1991;26: 227-259

Whittaker S, Smith N, et al.: Analysis of β , γ and δ T-Cell Receptor Genes in Mycosis Fungoides and Sezary Syndrome. Cancer 1991;68:1572-1582

Whittaker S: Molecular Genetics of Cutaneous Lymphomas. Ann N Y Acad Sci 2001;941: 39-45

Wieselthier J, Koh H et al.: Sézary Syndrome: Diagnosis, prognosis, and critical review of treatment options. J Am Acad Dermatol 1990;22(3):381-401

Willemze R., Kerl H., et al.: EORTC Classification for Primary Cutaneous Lymphomas: A Proposal From the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997;90(1):354-371

Willemze R., Meijer C.: EORTC Classification for Primary Cutaneous Lymphomas: The Best Guide to Good Clinical Management. The Am J Dermatopathol. 1999;21(3): 265-273

Wood G, Hong S, et al.: Leu-8/CD7 antigen expression by CD3+ T cells: Comparative analysis of skin and blood in mycosis fungoides/Sézary syndrome relative to normal blood values. J Am Acad Dermatol 1990;22:602-607

Wood G, Haeffner A, et al.: Molecular Biology Techniques for the diagnosis of cutaneous T-Cell Lymphoma. Dermatologic Clinics 1994;12(2):231-241

Zelickson B, Peters M, et al.: T-cell receptor gene rearrangement analysis: Cutaneous T cell lymphoma, peripheral T cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disorders. J Am Acad Dermatol 1991;25:787-796